Companies / BOC Sciences / Otelixizumab
BOC Sciences

Otelixizumab | BOC Sciences

(0) Write Review

Otelixizumab is a human anti-CD3 monoclonal antibody developed for the treatment of type 1 diabetes.

Reviews

(0) | Be the first to review this product
No reviews yet

ABOUT THE COMPANY

BOC Sciences
BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.
Scientific Products
  • See More
    • Upcoming Virtual Events
    Upcoming Webinars